PHILADELPHIA HEALTH AND EDUCATION CORPORATION D/B/A DREXEL UNIVERSITY COLLEGE OF MEDICINE;IMCLONE LLC
发明人:
NICK LOIZOS,NATHAN GRAEME DOLLOFF,ALESSANDRO FATATIS
申请号：
PT09075102
公开号：
PT2100618E
申请日:
2006.06.19
申请国别(地区):
PT
年份:
2014
代理人:
摘要：
The present invention concerns an effective amount of a PDGFR± antagonist for use as a medicament for treating subjects having a bone tumor and also for inhibiting growth of a bone tumor. The PDGFR± antagonist may be an antibody or antibody fragment. In certain embodiments the antagonist can be a bispecific antibody.
